Search results for " flu"
Article
Vaccine Development and Production Challenges Manufacturers
Flu vaccine challenges
Manufacturers faced serious difficulties in developing and producing seasonal influenza vaccines this past flu season, as production snafus forcedd key producers to delay vac…
Article
Modern Manufacturing Key to More Effective Vaccines
Reports that this year’s flu vaccine was only 36% effective have raised concerns about continued use of egg-based production systems that appear outdated and less reliable. And the imperative to comba…
Article
Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions
Following the 2009 outbreak of the H1N1 pandemic flu and the numerous delays in producing vaccines against the virus, the US Department of Health and Human Services (HHS) recognized the need to invest…
Article
Genetic Vaccine Platforms Demonstrate Their Potential
This is particularly true when creating vaccines for new mutations of known and treatable viruses such as flu,” Becker remarks.
“Traditional vaccines can take years to develop bec…
Article
Can Vaccine Development Be Safely Accelerated?
“All of the recent potentially pandemic viruses, including SARS and MERS and two flu viruses (avian and swine flu), have the common feature that they simply had never been seen before by the human imm…
Article
Vaccine Development Faces Urgency and Challenges
Efforts to establish more reliable and efficient supplies of seasonal influenza vaccine in the United States, moreover, have led to development and FDA approval of the first US adjuvant flu vaccine.
…
Article
Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
The objective of WHO’s global action plan (GAP) for influenza vaccines is to produce enough seasonal flu vaccine to immunize two billion people by 2015 (1). If facing a pandemic, the world would need …
Article
Top Process Development Trends for 2021 and a Look into 2022
And thanks to the spotlight COVID-19 vaccines put on mRNA therapies, they are being studied for use in cancers, including cancer vaccines, and other vaccinations such as the flu and bacterial infectio…
Article
Remote Monitoring and Big Data Advance Upstream Automation
As with the 2009 flu pandemic, Vann believes the current pandemic has driven interest in improved process understanding, performance, and quality. “Companies are looking to reduce process development …
Article
A Look at the Affinity Chromatography Landscape
In a pandemic situation, he notes that production of 40 million doses of flu vaccine is possible in one day with 54 L of membrane.
Nanofibers for affinity chromatography
A number of different …